Mid-Day Update: U.S. Stocks Lower in Midday Trade Amid Geopolitical Concerns

U.S. stock futures were down at midday Tuesday, with all three major indices in the red amid geopolitical concerns over sectarian wars in the Middle East along with conflict between Ukraine and Russia.

Investors were also digesting a job openings report along with small business sentiment data. The number of job openings in the U.S. in June rose to 4.67 million, according to the U.S. Department of Labor. Meanwhile, small business sentiment also rose

Crude oil for September delivery was down 0.90% to $97.20 per barrel. Natural gas was up 0.66% to $3.99 per 1 million BTU. Gold was up 0.43% to $1,316 an ounce, while silver was down 0.30% to $20.04 an ounce. Copper was down 0.57% to $3.16 per pound.

Among energy ETFs, the United States Oil Fund ( USO ) was down 0.72% to $35.97 with the United States Natural Gas ( UNG ) was down 0.09% to $21.90. Amongst precious-metal funds, the Market Vectors Gold Miners ETF ( GDX ) was up 2.15% at $27.55 while SPDR Gold Shares ( GLD ) were up 0.52% at $126.63. The iShares Silver Trust ( SLV ) was down 0.10% at $19.21.

Here's where the markets stand at mid-day:


NYSE Composite Index was down 0.27% at 10,694.04

Dow Jones Industrial Index was down 0.19% to $16,535

S&P 500 was down 0.25% at 1,932

Nasdaq Composite Index was down 0.35% at 4,386


FTSE 100 was down 0.04% at 6,629.95

DAX was down 1.19% at 9,071.85

CAC 40 was down 0.82% at 4,163.36

Nikkei 225 was up 0.20% at 15,161.31

Hang Seng Index was up 0.18% at 24,689.41

Shanghai China Composite Index was down 1.03% at 10.60


NYSE Energy Sector Index was up 0.56% at 14,849.97

NYSE Financial Sector Index was up 0.15% at 6,414.02

NYSE Healthcare Sector Index (NAR: NYP.ID) is up/down XXX (+/-XXX%) to XXX


*EXACT Sciences (EXAS), up 6.11% at $18.14, after the Food and Drug Administration approved Cologuard, the company's non-invasive, stool DNA colorectal cancer screening test

*United Online (UNTD), up 12.5% at $12.03 as Q2 revenue topped analysts' expectations, despite its loss widening year over year

*Intercept Pharmaceuticals Inc. (ICPT), up 26.5% at $300.00 on upgrade at Leerink Swann to an outperform rating from market perform, earnings results and product update


*Kate Spade (KATE) down 21% at $31.18 on conference call comments, Q2 loss misses Street target

*MannKind Corp. (MNKD) down 11%, losing Monday's gains on positive Q2 earnings

*Dendreon (DNDN), down 36% to $1.26 on required full repayment of 2016 notes and despite Q2 results, which beat the Street views

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 All rights reserved. Unauthorized reproduction is strictly prohibited.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More